As of 2024-12-14, the Relative Valuation of Jounce Therapeutics Inc (JNCE) is (16.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.88 USD, the upside of Jounce Therapeutics Inc based on Relative Valuation is -1003.1%.
The range of the Relative Valuation is (8.09) - (16.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 17.2x | 16.6x |
| Forward P/E multiples | 7.8x - 19.2x | 18.5x |
| Fair Price | (8.09) - (16.60) | (16.98) |
| Upside | -530.2% - -983.0% | -1003.1% |
| Date | P/E |